Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-15 Option Award |
2024-01-17 5:01 pm |
N/A 2034-01-15 |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer |
3,109,848 | $0 | 3,109,848 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:04 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer |
1,918,392 | $0 | 1,918,392 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-13 9:03 pm |
N/A 2032-01-12 |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer |
1,721,328 | $0 | 1,721,328 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-03 9:01 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer |
1,785,000 | $0.157 | 1,800,000 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-11 9:01 pm |
N/A 2031-01-11 |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer |
1,329,528 | $0 | 1,329,528 (Direct) |
View |
Ownership |
2021-01-04 8:08 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | TAYTON-MARTIN HELEN KATRINA Director |
0 | $0 | 538,294 (Direct) |
View |